DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Doxorubicin
Doxorubicin
August 2019: Additions and Deletions to the Drug Product List
Induction with Mitomycin C, Doxorubicin, Cisplatin And
Arsenic Trioxide Is Highly Cytotoxic to Small Cell Lung Carcinoma Cells
5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells
Characteristics of Doxorubicin‑Selected Multidrug‑Resistant Human Leukemia HL‑60 Cells with Tolerance to Arsenic Trioxide and Contribution of Leukemia Stem Cells
Cyclophosphamide-Doxorubicin Ver
Combination Chemotherapy with Estramustine Phosphate, Ifosfamide and Cisplatin for Hormone-Refractory Prostate Cancer
Chemotherapy Protocol
SAVACM Protocol
Protocol Code: BRAJACTW Tumour Group: Breast Contact Physician: Dr
Multiple Myeloma
Doxorubicin Liposome (Doxil®) Pronounced: “Doks-Oh-ROO-Bi-Sin Lye-Po-Soam”
Antitumor Antibiotics
Cyclophosphamide, Doxorubicin & Vincristine
Derivation of Anthracycline Equivalence to Doxorubicin in Relation to Late Cardiotoxicity: Epirubicin, Idarubicin and Mitoxantrone
Differential Uptake of Estramustine Phosphate Metabolites and Its Correlation with the Levels of Estramustine Binding Protein in Prostate Tumor Tissue
Large-Scale Drug Screening in Patient-Derived IDH Glioma Stem
DRUG NAME: Fluorouracil
Top View
North Carolina Division of Health Benefits Physician Administered Drug Program Catalog
2019 Table of Drugs
In Vitro and in Vivo Characterization of Doxorubicin and Vincristine
Acute Promyelocytic Leukemia Facts
Liposomal Doxorubicin
Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
HOPA News Volume 10, Issue 1
A Detailed Evaluation of Cardiac Toxicity: a Phase II Study of Doxorubicin and One- Or Three-Hour-Infusion Paclitaxel in Patients with Metastatic Breast Cancer1
Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory
In Vivo Evaluation of a Novel Albumin-Binding Prodrug of Doxorubicin in an Orthotopic Mouse Model of Prostate Cancer (Lncap)
For the Patient: ACT Other Names: BRAJACT
BRAJACTTG Protocol
1 Rhabdoid Tumors Are Sensitive to the Protein-Translation Inhibitor
Schedule-Dependent Synergism and Antagonism Between Methotrexate
Mutagenic and Cytotoxic Activity of Doxorubicin and Daunorubicin Derivatives on Prokaryotic and Eukaryotic Cells N
BC Cancer Protocol Summary for Adjuvant Therapy for Osteosarcoma Using Doxorubicin and Cisplatin
Do Not Administer Doxorubicin Hcl in Combination with Trastuzumab
Cisplatin Doxorubicin Sarcoma
Doxorubicin and Cyclophosphamide Followed by Docetaxel
Protocol: Doxorubicin/Cisplatin Indications: Osteosarcoma
BRLAACD Protocol
DOXORUBICIN Water for Injection USP and Doxorubicin Hydrochloride Injection Hydrochloric Acid USP for Ph Adjustment
Important Drug Information
Arsenic Trioxide (As 2 O 3) Gradually Downregulates Tissue Factor
Chemogenomic Screening Identifies the Hsp70 Co-Chaperone DNAJA1
(Ddmvac) with Gemcitabine and Cisplatin (GC) As Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis
203585Orig1s000
AC: Doxorubicin and Cyclophosphamide
Methotrexate, Paclitaxel, and Doxorubicin Radiosensitize HER2
FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
Inp RCODOX M(66) Cyclophosphamide Doxorubicin Methotrexate Rituximab Vincristine
Cyclophosphamide, Doxorubicin and Vincristine (CAV)
Cisplatin Doxorubicin Methotrexate Vinblastine (Accelerated) Ver1.1
Doxorubicin (Adriamycin®)
ADRIAMYCIN (Doxorubicin Hydrochloride) for Injection Is Followed by Rapid Plasma Clearance and Significant Tissue Binding
Long-Survival in Responding Patients with Metastatic Breast Cancer Treated with Doxorubicin-Docetaxel Combination
TAXOTERE Safely and Effectively
DRUG NAME: Daunorubicin
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE
Adriamyciin Rdf (Doxorubicin Hydrochloride) Injection Label
DRUG NAME: Doxorubicin
Cyclophosphamide, Doxorubicin, Vincristine
Treating Chronic Myeloid Leukemia If You’Ve Been Diagnosed with Chronic Myeloid Leukemia (CML), Your Treatment Team Will Discuss Your Options with You
Cardiac Sequelae of Doxorubicin and Paclitaxel As Induction